Trials / Completed
CompletedNCT01955044
PUFA Supplementation in Premature Infants
Early DHA Supplementation in Extremely Low Birth Weight Infants
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Endeavor Health · Academic / Other
- Sex
- All
- Age
- 72 Hours
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if buccal administration of a concentrated formulation of long-chain polyunsaturated fatty acids (LCPUFA) can help to maintain docosahexaenoic acid (DHA) levels in extremely low birth weight (ELBW) infants.
Detailed description
This will be a multi-center, randomized, placebo controlled, double blind trial. Two doses of PUFA will be compared to placebo- a "high" dose and a "low" dose. ELBW infants will be enrolled into this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | LCPUFA supplement | |
| DIETARY_SUPPLEMENT | placebo |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-04-01
- Completion
- 2016-04-01
- First posted
- 2013-10-07
- Last updated
- 2021-09-05
- Results posted
- 2016-03-29
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01955044. Inclusion in this directory is not an endorsement.